149 related articles for article (PubMed ID: 2506659)
1. Clotting activation and impairment of fibrinolysis in malignancy.
Rocha E; Páramo JA; Fernández FJ; Cuesta B; Hernández M; Paloma MJ; Rifón J
Thromb Res; 1989 Jun; 54(6):699-707. PubMed ID: 2506659
[TBL] [Abstract][Full Text] [Related]
2. Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia.
Tallman MS; Lefèbvre P; Baine RM; Shoji M; Cohen I; Green D; Kwaan HC; Paietta E; Rickles FR
J Thromb Haemost; 2004 Aug; 2(8):1341-50. PubMed ID: 15304040
[TBL] [Abstract][Full Text] [Related]
3. Coagulation and fibrinolysis after moderate and very heavy exercise in healthy male subjects.
Weiss C; Seitel G; Bärtsch P
Med Sci Sports Exerc; 1998 Feb; 30(2):246-51. PubMed ID: 9502353
[TBL] [Abstract][Full Text] [Related]
4. [Long-term hemodialysis and changes in variables of coagulation and fibrinolysis].
Uchida Y
Fukuoka Igaku Zasshi; 1991 Nov; 82(11):576-85. PubMed ID: 1774013
[TBL] [Abstract][Full Text] [Related]
5. Analysis of fibrin formation and proteolysis during intravenous administration of ancrod.
Dempfle CE; Argiriou S; Kucher K; Müller-Peltzer H; Rübsamen K; Heene DL
Blood; 2000 Oct; 96(8):2793-802. PubMed ID: 11023513
[TBL] [Abstract][Full Text] [Related]
6. Abnormalities of blood coagulation and fibrinolysis in psoriasis.
Marongiu F; Sorano GG; Bibbò C; Pistis MP; Conti M; Mulas P; Balestrieri A; Biggio P
Dermatology; 1994; 189(1):32-7. PubMed ID: 7516205
[TBL] [Abstract][Full Text] [Related]
7. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
8. Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors.
Weitz JI; Leslie B; Hudoba M
Circulation; 1998 Feb; 97(6):544-52. PubMed ID: 9494024
[TBL] [Abstract][Full Text] [Related]
9. Endothelial cell markers and fibrinopeptide A to D-dimer ratio as a measure of coagulation and fibrinolysis balance in normal pregnancy.
Bellart J; Gilabert R; Miralles RM; Monasterio J; Cabero L
Gynecol Obstet Invest; 1998; 46(1):17-21. PubMed ID: 9692335
[TBL] [Abstract][Full Text] [Related]
10. Blood coagulation after long distance running: antithrombin III prevents fibrin formation.
Bärtsch P; Haeberli A; Straub PW
Thromb Haemost; 1990 Jun; 63(3):430-4. PubMed ID: 2402746
[TBL] [Abstract][Full Text] [Related]
11. Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin.
Lassila R; Peltonen S; Lepäntalo M; Saarinen O; Kauhanen P; Manninen V
Arterioscler Thromb; 1993 Dec; 13(12):1738-42. PubMed ID: 8241093
[TBL] [Abstract][Full Text] [Related]
12. Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation.
Porte RJ; Bontempo FA; Knot EA; Lewis JH; Kang YG; Starzl TE
Transplantation; 1989 Jun; 47(6):978-84. PubMed ID: 2499962
[TBL] [Abstract][Full Text] [Related]
13. Fibrin generation and digestion in patients with angina pectoris.
Prisco D; Paniccia R; Francalanci I; Bandinelli B; Filippini M; Bacci F; Rostagno C; Abbate R; Gensini GF
Int J Clin Lab Res; 1995; 25(4):222-5. PubMed ID: 8788552
[TBL] [Abstract][Full Text] [Related]
14. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
Mombelli G; Monotti R; Haeberli A; Straub PW
Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
[TBL] [Abstract][Full Text] [Related]
15. Markers of coagulation and fibrinolysis in portal blood from patients with and without gastric malignancy.
Rahr HB; Sørensen JV; Larsen JF; Jensen FS; Bredahl C
Scand J Gastroenterol; 1994 Jun; 29(6):516-21. PubMed ID: 8079109
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of clotting and fibrinolytic activation after protracted physical exercise.
Prisco D; Paniccia R; Bandinelli B; Fedi S; Cellai AP; Liotta AA; Gatteschi L; Giusti B; Colella A; Abbate R; Gensini GF
Thromb Res; 1998 Jan; 89(2):73-8. PubMed ID: 9630310
[TBL] [Abstract][Full Text] [Related]
17. Fibrin metabolism in patients with acute myocardial infarction during and after treatment with tissue-type plasminogen activator.
Ring ME; Butman SM; Bruck DC; Feinberg WM; Corrigan JJ
Thromb Haemost; 1988 Dec; 60(3):428-33. PubMed ID: 2976994
[TBL] [Abstract][Full Text] [Related]
18. Fibrin degradation products generation and fibrinopeptide A release in normal plasma incubated with thrombolytic agents: proposed mechanisms.
Mirshahi M; Soria J; Bertrand O; Amiral J; Soria C
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):531-6. PubMed ID: 1723308
[TBL] [Abstract][Full Text] [Related]
19. Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.
Sidelmann JJ; Kluft C; Krug AH; Winkler U; Jespersen J; Gram JB
Thromb Haemost; 2017 Apr; 117(4):700-705. PubMed ID: 28150855
[TBL] [Abstract][Full Text] [Related]
20. Activation of blood coagulation and fibrinolysis in Graves' disease.
Marongiu F; Conti M; Murtas ML; Mameli G; Sorano GG; Martino E
Horm Metab Res; 1991 Dec; 23(12):609-11. PubMed ID: 1778596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
